Journal Report

Journal of Medical Economics

Download PDF
Journal Information
Journal Title
Journal of Medical Economics
Publisher
Taylor & Francis Online
ISSN
1369-6998
E-ISSN
1941-837X
Database
ABDC
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Comparison of 1-year costs of commercially insured patients with severe aortic stenosis undergoing surgical vs. transcatheter aortic valve replacement
Suzanne J. Baron, Benjamin Z. Galper, Marcella A. Kelley et al.
2026-10-30 Vol. 29 Issue 1 Pages 2624-2635
DOI: 10.1080/13696998.2026.2752763
Uncovering the full economic impact of biosimilars: a “would have spent” counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016–2025
Seungjae Yi, Minyoung Jang, Federico Di Biasio et al.
2026-10-28 Vol. 29 Issue 1 Pages 2587-2601
DOI: 10.1080/13696998.2026.2747522
Evaluating the cost-effectiveness of enhanced cardiovascular-renal-metabolic (CVRM) screening in UK, France, Germany and Australia: a microsimulation-based enhanced CVRM screening analysis
Fiona Adshead, Georgios Xydopoulos, Vasileios Vasilopoulos et al.
2026-10-27 Vol. 29 Issue 1 Pages 2602-2623
DOI: 10.1080/13696998.2026.2746285
Healthcare utilization and costs associated with dextromethorphan-bupropion versus selected other branded treatments for major depressive disorder: a US real-world study
Leslie Citrome, Yang Zhao, Courtney Zeni et al.
2026-10-21 Vol. 29 Issue 1 Pages 2572-2586
DOI: 10.1080/13696998.2026.2746279
Real-world utilization of gonadotropins and the associated cumulative live birth rates in the United States: a retrospective claims database analysis
Weiguang Xue, Emily Jungheim, Min Yang et al.
2026-10-21 Vol. 29 Issue 1 Pages 2527-2538
DOI: 10.1080/13696998.2026.2746278
Cost‑effectiveness analysis of the mRNA‑1345 RSV vaccine for older adults in Italy
Mariia Dronova, Camille Moyon, Lukasz Pyrek et al.
2026-10-19 Vol. 29 Issue 1 Pages 2552-2571
DOI: 10.1080/13696998.2026.2746277
Morbidity burden and healthcare costs in idiopathic multicentric Castleman disease (BURDEN-iMCD): a retrospective population-level matched cohort analysis
Ariela Noy, Robert Ohgami, Nikhil Munshi et al.
2026-10-18 Vol. 29 Issue 1 Pages 2508-2521
DOI: 10.1080/13696998.2026.2740922
Healthcare resource utilization and costs of US patients with small cell lung cancer treated with second-line therapies: a retrospective real-world database study
X. Fan, A. Nguyen, B. Rengarajan et al.
2026-10-17 Vol. 29 Issue 1 Pages 2491-2507
DOI: 10.1080/13696998.2026.2738358
Treatment patterns, healthcare utilization, and healthcare costs in patients with newly diagnosed type 1 diabetes: a retrospective real-world study in Tianjin, China
Wei Liu, Linong Ji, Yu Chen et al.
2026-10-15 Vol. 29 Issue 1 Pages 2464-2476
DOI: 10.1080/13696998.2026.2738350
From drug comparison to population health impact: rethinking value assessment in health technology evaluation
Clément Francois, Laurent Boyer, Pierre Michel Llorca
2026-10-15 Vol. 29 Issue 1 Pages 2522-2526
DOI: 10.1080/13696998.2026.2745423
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 1, 2026 18:51